Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triplet vs Doublet Therapy in Low Volume mHSPC
NCT06060587Phase 2Withdrawn
- Sponsor
- Northwestern University
- Start
- Oct 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by Northwestern University. Planned start Oct 2023; status: withdrawn.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06060587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06060587.